Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV ‐2 vaccine—A case review
Journal of the European Academy of Dermatology and Venereology · 2023
DOI: 10.1111/jdv.19305 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von K Kanabaj und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology, Venereology and Allergology, Gdański Uniwersytet Medyczny, Gdańsk, Poland. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Schnitzler Syndrome, Thyroiditis, Subacute. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology, Venereology and Allergology, Gdański Uniwersytet Medyczny, Gdańsk, Poland.
ORCID-Profile: K Kanabaj, M Sokołowska-Wojdyło
Zitieren
APA
Kanabaj, K., Sokołowska-Wojdyło, M., Wilkowska, A., & Nowicki, R. J. (2023). Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV ‐2 vaccine—A case review. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19305
Vancouver
Kanabaj K, Sokołowska-Wojdyło M, Wilkowska A, Nowicki RJ. Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV ‐2 vaccine—A case review. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.19305
BibTeX
@article{Kanabaj2023,
author = {Kanabaj, K and Sokołowska-Wojdyło, M and Wilkowska, A and Nowicki, R J},
title = {Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV ‐2 vaccine—A case review},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
doi = {10.1111/jdv.19305}
}
EUVIMED